AI Investment Business Regulation

The ADA Just Put Its Money Where AI Is

Dr Ali Vatan Ali Vatan
·

The American Dental Association has made its first-ever investment in a dental AI company. What does it mean when the profession's governing body picks a side?

The ADA Just Put Its Money Where AI Is

On 17 December 2024, the American Dental Association made a strategic investment in Pearl, the LA-based company behind the first FDA-cleared AI for reading dental radiographs. The ADA hasn’t disclosed the exact sum, but the signal matters more than the cheque.

I noticed this because the ADA represents over 160,000 dentists in the United States. It shapes policy, influences regulation, and sets the tone for what the profession considers legitimate. When an institution like that puts money into an AI company, I think every dentist should be paying attention.

Why Pearl, why now?

Pearl was founded in 2019 and built its reputation on computer vision for dental imaging. Its AI has regulatory clearance in over 120 countries and is designed to help clinicians make more precise diagnostic decisions from radiographs. The investment was led by the ADA’s Innovation Advisory Committee, which exists to identify technologies that could advance patient care and public health.

This isn’t the ADA’s first technology investment; they’ve previously backed Oral Genome and Overjet. But the timing is what interests me. It arrives as dental AI attracts unprecedented venture capital (over $145 million in 2024 alone) and the profession tries to work out what AI means for clinical practice.

I can understand why the ADA doesn’t want to be left behind.

Institutional endorsement carries weight

When the ADA invests in Pearl, it’s not just a financial transaction. It’s an endorsement. And endorsements from professional bodies carry enormous weight with member dentists who look to the ADA for guidance on everything from infection control to continuing education.

For practitioners who’ve been sceptical about AI, this sends a clear message: the governing body of American dentistry believes this technology has a place in clinical practice. For some dentists, it’s the nudge they needed. For others, it might feel like the profession is picking winners before the evidence is fully in.

I have some sympathy with both positions.

It’s easy to get swept up

I’ve watched demos where AI analyses a panoramic radiograph and highlights caries, bone loss, and periapical lesions in seconds. It looks like something new. It’s easy to get swept up in how a computer can seemingly think.

But thinking and proving are different things. I want to see long-term, real-world clinical data before I’m confident that AI-assisted diagnosis improves patient outcomes, not just diagnostic accuracy on curated datasets. There’s a gap between “this AI can identify a lesion on a radiograph” and “this AI makes patients healthier.”

The ADA’s investment is a vote of confidence, but it’s not a clinical trial. It’s not a systematic review. It’s a bet. An informed one, made by people who understand the landscape, but a bet.

What this means for UK dentistry

For those of us on this side of the Atlantic, the ADA’s move is worth watching. The British Dental Association hasn’t made equivalent investments and operates quite differently, but what happens in the US dental market tends to ripple outwards. If AI becomes standard of care in American practices, and the ADA’s endorsement accelerates that, it will eventually influence expectations here too.

The NHS raises its own questions about funding, training, data governance, and clinical responsibility. I don’t have neat answers for any of them. But the direction of travel is clear.

The real test

Pearl is a credible company with solid regulatory credentials, and I respect the intent behind the ADA’s move. But we’re still early.

The real test, to me, isn’t whether AI can read an X-ray. It’s whether it improves the care patients actually receive: catching things that would otherwise be missed, reducing diagnostic variability, making dentistry more equitable and more accessible. That’s what I’ll be watching for.

References